alexa Natural History Of Chronic Hepatitis C Development And Progression As A Consequence Of Iron And HFE Or TfR1 Mutations
ISSN: 2161-069X

Journal of Gastrointestinal & Digestive System
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

11th Global Gastroenterologists Meeting
June 12-13, 2017 Rome, Italy

Esam Elshimi, Wesam Saber Morad, Hala Hani El Said and Nermine Ahmed Ehsan
National Liver Institute, Egypt
Posters & Accepted Abstracts: J Gastrointest Dig Syst
DOI: 10.4172/2161-069X-C1-050
Abstract
Introduction & Aim: Heavy iron overload is toxic to virtually all cells and tissues. There is growing evidence that only modest amounts of iron in the liver may serve as a co-morbid factor to increase the severity and/or rate of progression of liver disease. Aim of this study is to explore the role of iron, HFE mutations, and polymorphisms of the TfR1 gene in the progression of chronic hepatitis C infection and possible therapeutic implications of iron overload on interferon therapy of patients with chronic hepatitis C. Methods: From 3rd October 2012 to 6th January 2016, we studied 300 consecutive patients with chronic hepatitis C, correlating clinical, laboratory, histopathological, and genetic data. Frequencies of genetic variations were compared with healthy controls. Results: HFE mutations were more common in patients than controls (25% vs. 11.7%, P=0.00006), and the C282Y mutation were more common in patients than controls (38.0% vs. 48.0%, P=0.02). Patients carrying C282Y had higher mean hepatic iron concentrations (P=0.02). Hepatic fibrosis was correlated with hepatic iron concentration (P=0.03). HFE and TfR1 polymorphisms bore detectable relation to disease severity and to response to interferon therapy. Conclusions: Hepatic iron and HFE andTfR1mutations are co-morbid factors that increase progression of chronic hepatitis C and decrease the response to interferon therapy.
Biography

Esam Elshimi is working at Menoufia University, Egypt. He is the recipient of numerous awards for his research works in related fields. His research interests reflect in his wide range of publications in various national and international journals.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords